SCHEMBL166495

SCHEMBL166495

Cc1ccc(C(=O)c2ccccc2)cc1C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.71
CES2 O00748 1/20 0.71
CES1 P23141 1/20 0.71
HTT P42858 1/20 0.71
ALDH1A1 P00352 6/20 0.68
NPC1 O15118 5/20 0.68
POLB P06746 2/20 0.68
MITF O75030 1/20 0.68
LMNA P02545 1/20 0.68
TDP1 Q9NUW8 2/20 0.61
ATM Q13315 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
MAPT P10636 3/20 0.61
SRD5A2 P31213 1/20 0.56
MAPK1 P28482 1/20 0.55
RAB9A P51151 5/20 0.54
KMT2A Q03164 2/20 0.54
HPGD P15428 3/20 0.54
CASP3 P42574 1/20 0.54
SENP8 Q96LD8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10007010 1.00 SMN1; SMN2 (0.71) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL13236538 0.96 TDP1 (0.69) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL822303 0.91 SMN1; SMN2 (0.83) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL9392038 0.89 NPC1 (0.76) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL47827 0.89 SMN1; SMN2 (0.79) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL29514906 0.89 SMN1; SMN2 (0.79) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL27972378 0.88 SMN1; SMN2 (0.71) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL29060736 0.87 ALDH1A1 (0.62) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL12792138 0.86 POLB (0.67) SMN1; SMN2CES2CES1HTTALDH1A1
SCHEMBL10304768 0.86 CES2 (0.59) SMN1; SMN2CES2CES1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1954 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122037808-A Adhesive tape 长兴材料工业股份有限公司 2026-05-15 CN claimed
US-20260132314-A1 ADHESIVE TAPE ETERNAL MATERIALS CO., LTD. (TW) 2026-05-14 US claimed
EP-4455168-B1 VISIBLE LIGHT CURABLE COMPOSITION AND VISIBLE LIGHT CURABLE COMPOSITION POLYMERIZATION METHOD CHT TURKEY KIMYA SANAYI VE TICARET A S (TR) 2025-12-24 EP claimed
EP-4633900-A1 SACRIFICIAL ADDITIVELY MANUFACTURED MOLD WITH CONTROLLED MOISTURE AND LIQUID ABSORPTION PROPERTIES STRATASYS, INC. (US) 2025-10-22 EP claimed
EP-4606840-A2 ISOCYANATE-FREE POLYURETHANE AND ISOCYANATE-FREE POLYURETHANE-CONTAINING POLYMERIC FILM PRODUCTION METHOD CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2025-08-27 EP claimed
WO-2025106936-A1 POLY(METH)ACRYLIMIDE MATERIALS WITH ENHANCED THERMOMECHANICAL PROPERTIES GENCORES, INC. (US) 2025-05-22 WO claimed
WO-2025014975-A2 LUBRICIOUS COATINGS FOR SKIS AND SNOWBOARDS AND RELATED SYSTEMS AND METHODS OF USE Drake Holdings, Inc. (US) 2025-01-16 WO claimed
CN-111936117-B Covalent treatment of keratin-containing materials 生活实验公司 2025-01-07 CN claimed
WO-2025005739-A1 BARRIER MEMBRANE FOR BONE REGENERATION TO MAINTAIN MICROORGANISM-CELL SYMBIOSIS AND METHOD FOR PRODUCING SAME 연세대학교 산학협력단 2025-01-02 WO claimed
EP-4455168-A1 VISIBLE LIGHT CURABLE COMPOSITION AND VISIBLE LIGHT CURABLE COMPOSITION POLYMERIZATION METHOD CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) 2024-10-30 EP claimed
WO-2008027515-A2 PHOSPHORUS-CONTAINING STABILIZERS FOR FLUOROOLEFINS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-03-06 WO claimed
WO-2008027511-A1 EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-03-06 WO claimed
WO-2007143659-A2 CROSSLINKED, DEGRADABLE POLYMERS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-12-13 WO claimed
WO-2007134219-A2 IN SITU POLYMERIZATION FOR SKIN TREATMENT LIVING PROOF, INC. (US) 2007-11-22 WO claimed
WO-2007127065-A2 IN SITU POLYMERIZATION FOR HAIR TREATMENT LIVING PROOF, INC. (US) 2007-11-08 WO claimed
WO-2007126760-A2 COMPOSITIONS COMPRISING IODOTRIFLUOROMETHANE AND STABILIZERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-11-08 WO claimed
EP-0674233-B1 Recording sheets XEROX CORP (US) 2000-05-24 EP claimed
US-5928765-A Recording sheets XEROX CORPORATION (US) 1999-07-27 US claimed
EP-0674233-A2 Recording sheets XEROX CORPORATION (US) 1995-09-27 EP claimed
US-4425404-A MULTILAYER, PROTECTIVE COATINGS MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1984-01-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132314-A1 ADHESIVE TAPE GGH, ALKBH3, OGDH SMN1; SMN2 3641/4885CES2 2748/4885CES1 3154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.